NYLI WMC Value Class R6 (MMPDX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
30.62
-0.02 (-0.07%)
At close: Apr 17, 2025
0.89% (1Y)
Fund Assets | 960.97M |
Expense Ratio | 1.02% |
Min. Investment | $0.00 |
Turnover | n/a |
Dividend (ttm) | 1.67 |
Dividend Yield | 5.45% |
Dividend Growth | 23.01% |
Payout Frequency | Annual |
Ex-Dividend Date | Dec 9, 2024 |
Previous Close | 30.64 |
YTD Return | -3.62% |
1-Year Return | 5.98% |
5-Year Return | n/a |
52-Week Low | n/a |
52-Week High | n/a |
Beta (5Y) | n/a |
Holdings | 71 |
Inception Date | Apr 26, 2021 |
About MMPDX
The NYLI WMC Value Class R6 (MMPDX) seeks to earn income as a secondary objective. MMPDX normally invests at least 65% of its total assets in equity-type securities.
Category Large Value
Performance Rating Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol MMPDX
Share Class Class R6
Index Russell 1000 Value NR
Performance
MMPDX had a total return of 5.98% in the past year, including dividends. Since the fund's inception, the average annual return has been 5.30%.
Top 10 Holdings
24.37% of assetsName | Symbol | Weight |
---|---|---|
JPMorgan Chase & Co. | JPM | 4.22% |
UnitedHealth Group Incorporated | UNH | 3.62% |
Johnson & Johnson | JNJ | 2.79% |
Cisco Systems, Inc. | CSCO | 2.77% |
Pfizer Inc. | PFE | 1.93% |
Elevance Health, Inc. | ELV | 1.88% |
MetLife, Inc. | MET | 1.81% |
Emerson Electric Co. | EMR | 1.80% |
Boston Scientific Corporation | BSX | 1.78% |
Mainstay Funds Trust - Main US Government Liquidity Fund | MUSXX | 1.76% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 9, 2024 | $1.66767 | Dec 9, 2024 |
Dec 6, 2023 | $1.35574 | Dec 6, 2023 |
Dec 7, 2022 | $1.6789 | Dec 7, 2022 |
Dec 2, 2021 | $25.93853 | Dec 2, 2021 |